Alan Sachs, MD, PhD, is the Chief Scientific Officer for Thermo Fisher Scientific. Dr. Sachs leads efforts to maximize growth through investments in R&D that help customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, and increase laboratory productivity. He served as the Chief Scientific Officer for Life Technologies and Life Sciences Solutions Group within Thermo Fisher between 2012 and 2015. Prior to this role, Dr. Sachs was the Vice President of Exploratory and Translational Sciences at Merck Research Laboratories. During his 10 years at Merck, he built and directed the global RNA Therapeutics Department, led the Rosetta Inpharmatics group, and led the Department of Molecular Profiling.
Before joining Merck, Dr. Sachs was an Associate Professor of Molecular and Cell Biology at the University of California, Berkeley, and a Whitehead Institute Fellow at the Whitehead Institute. Dr. Sachs graduated from Cornell University with a BA in Biochemistry; and from Stanford Medical School with an MD, a PhD with Roger Kornberg, and post-doctoral research with Ron Davis. Dr. Sachs serves on the Board of Directors for Imago BioSciences and the Advisory Board for The Bakar Fellows at University of California, Berkeley.